3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Small Cell Lung Carcinoma
1
Liver Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Interventions
Cisplatin
5
Gemcitabine
4
Oxaliplatin
2
Irinotecan
2
Fluorouracil
2
Capecitabine
2
Bevacizumab
2
zanidatamab
1
toripalimab
1
pembrolizumab
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
durvalumab
1
binimetinib
1
Trastuzumab
1
Pemetrexed
1
Nivolumab
1
Folfox protocol
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Actigraphy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
tremelimumab
×
30 days
×
Clear all
No trials found.